Comparative effect of intraduodenal and intrajejunal glucose infusion on the gut-incretin axis response in healthy males (#70)

4:00 PM

Tongzhi Wu

ADS Clinical Orals: Gut and Glycaemia

Effects of vildagliptin and/or a whey preload on postprandial glycaemia in patients with type 2 diabetes using metformin (#259)

2:00 PM

Tongzhi Wu

ADS Clinical Poster Prize Presentations

Relationships of ‘Early’ And ‘Late’ Glycaemic Responses With Gastric Emptying During An Oral Glucose Tolerance Test In Subjects With Normal Glucose Tolerance, Impaired Glucose Tolerance And Type 2 Diabetes (#285)

2:00 PM

Chinmay S Marathe

ADS Clinical Poster Viewing: Glycaemia/Monitoring

The glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, inhibits small intestinal motility, flow, transit and absorption of glucose in health and type 2 diabetes: a randomised controlled trial.  (#71)

4:15 PM

Chinmay S Marathe

ADS Clinical Orals: Gut and Glycaemia

Effects of exenatide on the blood pressure and heart rate responses to intraduodenal glucose in type 2 diabetes (#168)

4:30 PM

Chinmay S Marathe

ADS Clinical Orals: Therapies for Type 2 Diabetes

Increased Capacity for Intestinal Serotonin Release in Obese and Diabetic Humans (#8)

9:00 AM

Richard L Young

ADS Clinical Orals: Obesity

Regional Variation in Expression of Enzymes that Synthesise Incretin Hormones and Glucagon in Lean and Morbidly Obese Humans (#265)

2:00 PM

Richard L Young

ADS Clinical Poster Viewing: Pot Pourri

A low-dose whey protein preload slows gastric emptying and improves post-prandial glycaemia in type 2 diabetes (#69)

3:45 PM

Linda E Mignone

ADS Clinical Orals: Gut and Glycaemia

Effects of exogenous glucagon-like peptide-1 on the blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in healthy older subjects and type 2 diabetes. (#92)

9:15 AM

Laurence G Trahair

ADS Clinical Young Investigator Awards

Intestinal fatty acid sensor (FFAR4) and transporter (CD36) expression are significantly correlated with body mass index, and are not altered by acute fat exposure in lean, overweight or obese humans (#6)

8:30 AM

Nada Cvijanovic

ADS Clinical Orals: Obesity